| KIF5A Protein — Kinesin-5A Motor Protein | |
|---|---|
| Symbol | KIF5A |
| Full Name | Kinesin Family Member 5A |
| Molecular Weight | ~110 kDa (heavy chain) |
| UniProt | P33175 |
| Gene | KIF5A |
| Protein Family | Kinesin-1 family |
| Expression | Neuronal (CNS and PNS), axonal compartments |
| Diseases | ALS, HSP, CMT2 |
Kif5A Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The KIF5A protein (Kinesin Family Member 5A) is a neuronal-specific kinesin-1 motor protein that mediates anterograde axonal transport in neurons 1. As a molecular motor, KIF5A converts chemical energy from ATP hydrolysis into mechanical work, walking along microtubule tracks to transport cargo from the cell body to synaptic terminals. The protein is encoded by the KIF5A gene located on chromosome 12q13.3 and is essential for neuronal survival and function.
KIF5A belongs to the kinesin-1 family (conventional kinesins), which were the first kinesins discovered and remain the most studied. Mutations in KIF5A cause several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS), hereditary spastic paraplegia (HSP), and Charcot-Marie-Tooth disease type 2 2.
KIF5A has a characteristic kinesin-1 domain structure:
N-terminal Motor Domain (1-350 aa): Contains the microtubule-binding site and ATPase activity. This globular domain binds to microtubules and hydrolyzes ATP to generate force.
Neck Linker (350-400 aa): A flexible region that connects the motor domain to the coiled-coil stalk. The neck linker undergoes conformational changes during the catalytic cycle, determining step size and directionality.
Coiled-coil Stalk (400-700 aa): Forms a parallel coiled-coil that mediates dimerization with another KIF5A (or KIF5B/KIF5C) heavy chain.
C-terminal Tail (700-1000 aa): The tail domain binds to cargo adaptors and regulatory proteins. It contains the light chain binding region.
Multiple KIF5A isoforms are generated through alternative splicing:
Isoform expression is developmentally regulated, with neuronal isoforms predominating in the adult brain.
KIF5A operates through a nucleotide-dependent cycle often called the "hand-over-hand" mechanism:
This process allows KIF5A to take ~8 nm steps, corresponding to the tubulin dimer spacing on microtubules 3.
KIF5A is highly processive, taking hundreds of steps without detaching. This processivity is mediated by:
KIF5A is the primary kinesin for anterograde transport in axons:
| Cargo Type | Adaptor | Function |
|---|---|---|
| Synaptic Vesicles | KLC, Munc13 | Neurotransmission |
| Mitochondria | Miro, Milton | Energy supply |
| Neurofilaments | NF-L subunits | Cytoskeleton |
| RNA Granules | ZBP1, Staufen | Local translation |
| Protein Complexes | JIP1-3, HAP1 | Signaling |
KIF5A-mediated transport is essential for:
KIF5A, in complex with Miro and Milton, transports mitochondria to regions of high energy demand:
KIF5A mutations disrupt axonal transport through several mechanisms 2:
These defects lead to:
HSP-causing mutations typically affect the motor domain, causing:
CMT2 mutations in KIF5A cause peripheral neuropathy through:
The study of Kif5A Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.